Skip to main content
Premium Trial:

Request an Annual Quote

CureOne, Washington University Partner to Link NGS Data With Treatment Information

NEW YORK (GenomeWeb) – Washington University School of Medicine has partnered with the nonprofit CureOne to link cancer genomic data with treatment information.

CureOne will work with Wash U's Genomics and Pathology Services (GPS) laboratory, which offers clinical NGS-based cancer tests, to share data through CureOne's N1 Registry, an open-access database that links NGS data with information about treatment and clinical outcomes.

The nonprofit, formerly known as MED-C, is working to standardize clinical genomic data. In 2015, it received funding to launch a registry in non-small cell lung cancer. Earlier this year, both Foundation Medicine and Guardant Health also agreed to participate in its N1 Registry.

CureOne's goal is to "start harnessing and standardizing the data that makes it possible" to find cures to cancer, CureOne Founder and CEO Dane Dickson said in a statement.

"In collaboration with CureOne, we'll provide high-quality, mutational profiles for patients enrolled in this registry, hopefully across many different cancer types," added GPS Chief Medical Officer Jon Heusel. "The need for this kind of comprehensive data is great and long overdue."

The Scan

Denisovan Girl's Tooth Found in Laos

CNN reports that a tooth found in a cave north of Vientiane likely belonged to a Denisovan girl.

A Lack of Diversity in Trials

A new report from the National Academies of Science, Engineering, and Medicine examines the limited representation of diverse groups among clinical trial participants.

Another Look

A new inquiry is to be held after genetic evidence indicates that Kathleen Folbigg's children may have been at increased risk of sudden death, the Sydney Morning Herald reports.

Nucleic Acids Research Studies on ICARUS, Neighbor-seq, CADDIE

In Nucleic Acids Research this week: resource to analyze and visualize single-cell RNA-seq data, method to examine cellular interactions, and more.